STOCK TITAN
  1. Home
  2. News
  3. CLVRW

Clever Leaves Holdings Inc - CLVRW STOCK NEWS

Welcome to our dedicated news page for Clever Leaves Holdings (Ticker: CLVRW), a resource for investors and traders seeking the latest updates and insights on Clever Leaves Holdings.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Clever Leaves Holdings's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Clever Leaves Holdings's position in the market.

News
Clever Leaves Reports Fourth Quarter and Full Year 2023 Results
Rhea-AI Summary
Clever Leaves Holdings Inc. reported a 6% increase in revenue for 2023, driven by a 39% rise in full-year cannabinoid revenue. The company also achieved a 26% reduction in general and administrative expenses in Q4 2023 and a 24% reduction for the full year. Additionally, Clever Leaves completed the sale of its non-cannabinoid herbal brands business for $8.02 million, enhancing its focus on the cannabinoid segment.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.4%
Tags
earnings
-
News
Clever Leaves and Paradise Seeds to Develop and Register Genetic Assets in Colombia
Rhea-AI Summary
Clever Leaves Holdings Inc. partners with Paradise Seeds to develop and register high-performance cannabis cultivars in Colombia, aiming to expand its global footprint. This collaboration marks the first agronomic registrations of Paradise genetics in Colombia, enabling licensed cultivation and production of Paradise strains for export to global medicinal cannabis markets.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.09%
Tags
none
-
News
Clever Leaves Granted Australian GMP Certification for Cannabis Products by the Therapeutic Goods Administration (TGA)
Rhea-AI Summary
Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW), a global medicinal cannabis company, has been granted Australian GMP certification by the TGA for the manufacturing of cannabis products in Colombia. This makes Clever Leaves the first and only medicinal cannabis company globally with GMP certifications from the European Union, Colombia, Brazil, and Australia.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
11.49%
Tags
none
News
Clever Leaves Reports Third Quarter 2023 Results
Rhea-AI Summary
Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) reports Q3 revenue increase of 33% YoY, driven by 135% YoY growth in cannabinoid revenue. Adjusted EBITDA improved YoY to $(2.6) million. Cash balance at October 31, 2023, was $6.2 million. Updated full-year 2023 guidance reflects revenue timing shifts and adjusted EBITDA improvement.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.5%
Tags
earnings
-
News
Clever Leaves to Hold Third Quarter 2023 Conference Call on Thursday, November 9, 2023 at 5:00 p.m. ET
Rhea-AI Summary
Clever Leaves Holdings Inc. will hold a conference call on November 9, 2023, to discuss its Q3 2023 financial results. The call will be hosted by Clever Leaves management and will include a question-and-answer session. The conference call will be broadcast live and available for replay. Toll-free and international dial-in numbers are provided.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.6%
Tags
earnings
-
News
Clever Leaves Regains Compliance with Nasdaq Minimum Bid Price Requirement
Rhea-AI Summary
Clever Leaves regains compliance with Nasdaq minimum bid price requirement
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.13%
Tags
none
News
Clever Leaves Cannabis Operations Declared Carbon Neutral; a First for a Vertically Integrated Medicinal Cannabis Company
Rhea-AI Summary
Clever Leaves awarded International Declaration of Carbon Neutrality for commitment to sustainability
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10.19%
Tags
none
-
News
Clever Leaves Announces 1-For-30 Reverse Stock Split to Aid Compliance with Nasdaq Listing Requirements
Rhea-AI Summary
Clever Leaves approves 1-for-30 reverse split of common shares
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-15.89%
Tags
none
-
News
Clever Leaves Reports Second Quarter 2023 Results
Rhea-AI Summary
Clever Leaves reports 21% YoY revenue growth, driven by 151% YoY growth in cannabinoid revenue. Expense reductions lead to improved Adjusted EBITDA performance of ($2.1) million. Sale of Portuguese processing assets adds $2.7 million in cash. Reaffirms 2023 guidance: revenue $19-22M, adjusted gross margin 58-63%, adjusted EBITDA $(13.6)-(10.6)M.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.76%
Tags
earnings
News
Clever Leaves to Hold Second Quarter 2023 Conference Call on Monday, August 14, 2023 at 5:00 p.m. ET
Rhea-AI Summary
Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW), a global medicinal cannabis company, will hold a conference call on August 14, 2023, at 5:00 p.m. Eastern time to discuss its second-quarter results. The company will provide its financial results in a press release prior to the call.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.74%
Tags
earnings
Stock CLVRW logo
Clever Leaves Holdings Inc

Nasdaq:CLVRW

CLVRW Rankings

N/A Ranked by Market Cap
N/A Ranked by Stock Gains
N/A Ranked by Dividends

CLVRW Stock Data

1.63M
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
Colombia
Tocancipá

About CLVRW

clever leaves, a colombian company fully-licensed, will become the world’s largest grower with over 10mm+ ft2 of cultivation capacity by 2023, the largest extractor with pharmaceutical grade and gmp certified processing facilities, and the lowest cost operator in cannabis exports. one of the first colombian license holders in the medical cannabis industry. a company positioned to become a leader in the global market with a differentiated business model and strong positioning with regulators, physicians, and other relevant players. developing key capabilities to win in the new space of the medical cannabis industry with a highly experienced and respected team.